top of page

Search Results

Results found for "GPCR training program"

  • Profiling Immune Cell and Platelet Transcriptomes

    G protein-coupled receptors (GPCRs) are integral to cellular signaling, influencing a wide array of physiological advancements in transcriptomic profiling have provided new insights into the expression patterns of GPCRs The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 to 206, while platelets exhibit a distinct profile with 69 GPCR mRNAs. abundant and rare GPCR transcripts.

  • Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!

    GPCR Ecosystem Member, you've been with us as we've laid the groundwork for something truly special. pharmacology concepts, master new ones, and sharpen your thinking to directly advance your drug discovery program GPCR Ecosystem, we're giving Dr. GPCR Premium Members a significantly reduced access  to Terry's Corner for a limited time.   GPCR Team & Terry’s Desk

  • Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology

    GPCR ecosystem members!  GPCR ecosystem.  Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery Beth:  “Well, I enjoy training and mentoring team members.  GPCR

  • Pharmacology at Your Fingertips: Terry’s Corner Launches

    Elevate your drug discovery program with 45+ lessons yearly. go/no-go points, and de-risking programs from hit validation through development candidate selection systems, it turns scattered data into decisions, accelerating your path to a successful preclinical program Read The Full Article GPCR Publication Highlights   Chemokine–GPCR Selectivity Unveiled Sequence- and GPCR Team Join Our Newsletter!

  • When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission

    Lived Experience in Science What makes Serafini’s trajectory so compelling isn’t just his technical training researchers needs to start from lived experience, not just literature. _________________ Keyword Cloud: GPCR research community , chronic pain , GPCR drug discovery , GPCR scientist network , pain neuroscience

  • From Lab Bench to Boardroom: The Unexpected Path of a Medicinal Chemist

    GPCR Podcast, she shares how her background in medicinal chemistry paved the way to co-founding Celtarys , a company now shaping the future of GPCR assay tools. A postdoc in Santiago de Compostela introduced her to GPCRs, and from there, things escalated quickly drug discovery , GPCR research community , medicinal chemistry , Dr. GPCR ecosystem , GPCR online course , GPCR scientist network

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Ahoy, GPCR Crew! Interview Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and in Oncology and Immunology GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis Methods & Updates in GPCR Research GPCRSPACE: A New GPCR Real Expanded

  • The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway

    How Misalignment Drains Your Runway 👉 Misalignment doesn’t show up as chaos. Just one more backup program. Just one more exploratory study. Your story gets fuzzy. Conclusion: Don’t Let Misalignment Drain Your Future Misalignment rarely announces itself.

  • Beyond the Probe: Scaling Innovation From the Bench to Product Launch

    GPCR Podcast, Dr. Maria Majellaro makes it clear that Celtarys isn’t just a ligand provider. GPCR so powerful. “We don’t just deliver compounds, we solve assay problems.” — Dr. GPCR ecosystem , Celtarys is opening up that model to the broader research community. The goal? . _______________ Keyword Cloud:   GPCR data platform , fluorescent ligands , assay development , GPCR GPCR ecosystem , GPCR webinar series

  • 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024

    Ho, ho, ho, GPCR elves! As the year wraps up, we're thrilled to present the final edition of the GPCR Weekly Newsletter for 2024 GPCR ecosystem! Best, Yamina & the Dr. Don't miss out—upgrade now to keep up with your GPCR updates! Classified GPCR News  Let’s dive into the   Classified GPCR News from December 9th to 15th, 2024 Industry

  • Signals in Motion: Pain, Metabolism & Terry’s Corner

    Hello GPCR Innovators ,   We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Terry Kenakin’s decades of GPCR insight. delivers selective pain relief in preclinical models Dr.GPCR Updates Terry’s Corner  – Build Better GPCR Stay curious, stay connected, because the future of GPCR science is being written pathway by pathway. GPCR Team

  • Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025

    Here you can find the full program . Figure 1. UIC Student Center East. There were several sections, among them one specific for GPCRs. Sometimes when you’re in the field you forget the importance GPCRs holds in drug development as a whole Session 4 on Wednesday was dedicated to GPCRs. The talks given targeted both traditional GPCRs such as the serotoninergic receptor 5HT1A, but also newer

  • Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...

    Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4 WHIM syndrome is a rare immunodeficiency disorder that is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. While several gain-of-function mutations that lead to C-terminal truncations, frame shifts and point mutations in the chemokine receptor CXCR4 have been identified in WHIM syndrome patients, the functional effect of these mutations are not fully understood. Here, we report on a new WHIM syndrome mutation that results in a frame shift within the codon for Ser339 (S339fs5) and compare the properties of S339fs5 with wild type CXCR4 and a previously identified WHIM syndrome mutant, R334X. The S339fs5 and R334X mutants exhibited significantly increased signaling compared to wild type CXCR4 including agonist-promoted calcium flux and extracellular signal-regulated kinase activation. This increase is at least partially due to a significant decrease in agonist-promoted phosphorylation, β-arrestin binding, and endocytosis of S339fs5 and R334X compared to wild type CXCR4. Interestingly, there were also significant differences in receptor degradation, with S339fs5 having a very high basal level of degradation compared to that of R334X and wild type CXCR4. In contrast to wild type CXCR4, both R334X and S339fs5 were largely insensitive to CXCL12-promoted degradation. Moreover, while basal and agonist-promoted degradation of wild type CXCR4 was effectively inhibited by the CXCR4 antagonist TE-14016, this had no effect on the degradation of the WHIM mutants. Taken together, these studies identify a new WHIM syndrome mutant, CXCR4-S339fs5, that promotes enhanced signaling, reduced phosphorylation, β-arrestin binding and endocytosis, and a very high basal rate of degradation that is not protected by antagonist treatment. Read full article

  • Building Backwards: Why Top-Down Models Could Revolutionize Pain Research

    This allows him to see how inflammation, cognition, and pain circuits overlap , and how GPCRs might serve And it challenges the GPCR community to use its tools not just to explain, but to intervene. the case for building pain research from the clinic down, not the bench up. ________ Keyword Cloud: GPCR podcast , pain modeling , GPCR online course , translational research , neuroimmune signaling .

  • APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking

    Significant advancements in the cellular biology of G protein-coupled receptors (GPCRs) about a novel fluorescence serves as a readout for the activity of APEX2 and, by extension, the trafficking of the GPCR The development of molecular tools to study GPCR trafficking in real-time opens new avenues for understanding The implications of this research extend beyond basic science ; understanding the role of DNAJC13 in GPCR field continues to evolve, this study represents a crucial step toward unraveling the understanding of GPCR

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    . _________________ Keyword Cloud: GPCR online course, early-career scientists, imposter syndrome, GPCR podcast, neuroma model

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    This session unpacks how persistent binding can either accelerate your program—or quietly kill it. For teams running early-stage programs, recognizing this decoupling early can sharpen dose optimization Getting this wrong doesn’t just slow a program—it can mislead the entire development strategy . Join Terry’s Corner and get: Frameworks proven in real discovery programs On-demand lessons  designed Kenakin with your own enzyme or GPCR interaction puzzles.

  • Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...

    Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple A total of 41 neuropeptide GPCR genes belonging to three classes were also identified. These GPCRs and their probable ligands were predicted. expression patterns of these 98 genes in various larval tissues were evaluated using quantitative real-time PCR to determine physiological functions and pharmacological characterization of neuropeptides and their GPCRs

  • Target Residence Time: The Hidden Driver of In Vivo Efficacy

    volume of distribution hides the drug from its target When Potency Isn’t Enough Drug discovery teams are trained In structured, diffusion-restricted environments (e.g. brain, tumors), drugs don't just leave slowly; And when receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where Redefine Your Pipeline If your development program is built around potency alone, you may be leaving

  • Do You Believe AI Could Accelerate Drug Discovery?

    G protein-coupled receptors (GPCRs) are major drug targets, yet their complex and dynamic structures By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy One significant concern is the reliance on data quality and quantity, where inaccuracies or biases in training

  • Fentanyl and Xylazine: Why Breathing Fails in Overdose

    Watch Episode 172 The Bigger Picture: GPCR Science Meets Public Health At its core, Catherine Demery’ For scientists, this means rethinking how we study GPCR-mediated respiratory depression. For scientists, they sharpen our understanding of how different GPCR systems interact to produce respiratory In other words, this is GPCR science with immediate, life-or-death consequences.

  • The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...

    all cytomegalovirus (CMV) genomes analysed to date is the presence of G protein-coupled receptors (GPCR IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate All cytomegalovirus (CMV) genomes analysed to date possess GPCR homologs with phylogenetic evidence for The mouse CMV (MCMV) GPCR homolog, designated M33, is important for cell-associated virus spread and The signalling repertoire of M33 is distinct from cellular GPCRs and little is known of the relevance

  • In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...

    Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition Functional GPCR assays unfolded the compound's antagonist behavior on D1R (IC50 42.1 ± 0.35 μM) and agonist

  • Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...

    Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction G protein-coupled receptors (GPCRs The β2-adrenergic receptor (β2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. regulation that may contribute to biased signaling at GPCRs. We characterized the effects of extracellular loop mutations on agonist-promoted interactions of GPCRs

  • Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation

    bilayer creates is dynamic and interactive, becoming the foundation for many interactions involved in GPCR activation of GPCRs2. β-arrestins are cytosolic proteins that translocate to the plasma membrane upon GPCR Understanding the interplay between GPCRs and β-arrestins and how this complex operates on the plasma Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics. Molecular mechanism of GPCR-mediated arrestin activation.

  • Phospholipid Scrambling by G Protein-Coupled Receptors

    Unexpectedly, Class A G protein-coupled receptors (GPCRs), a large class of signaling proteins exemplified transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid) through a card reader (GPCR Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling In this review, we discuss the physiological significance of GPCR scramblase activity and the modes of

  • TLR4 biased small molecule modulators

    Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors (GPCRs The biased signaling modulation of non-GPCR receptors has yet to be exploited. Toll-like receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent modulators of TLR4 would provide insight for the future development of biased modulators for other non-GPCR

  • Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...

    this study was to identify Gα proteins mediating function of neuronal G protein-coupled receptors (GPCRs Some neuronal GPCRs (such as GTR-1, DCAR-1, DOP-2, NPR-8, NPR-12, NPR-9, and DAF-37) functioned upstream of GOA-1, some neuronal GPCRs (such as DCAR-1, DOP-2, NPR-9, NPR-8, and DAF-37) functioned upstream of GSA-1, and some neuronal GPCRs (such as DOP-2, NPR-8, DAF-37, and DCAR-1) functioned upstream of GPA Our results provide clues for understanding the important function of GPCRs-Gα signaling cascade in the

  • Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation

    Engineered G protein-coupled receptors (GPCRs) are commonly used in chemogenetics as designer receptors Although several GPCRs have been studied in astrocytes using a chemogenetic approach, the functional role of the astrocytic Gi pathway is not clear, as the literature is conflicting depending on the brain between enhanced calcium transients and the inflammatory phenotype of astrocytes observed in the inflamed brain

  • Precise druggability of the PTH type 1 receptor

    Class B G protein-coupled receptors (GPCRs) are notoriously difficult to target by small molecules because Using the parathyroid hormone type 1 receptor (PTHR) as a prototypic class B GPCR target, and a combination precise druggable sites and identify allosteric modulators of PTHR signaling that could be extended to GPCRs

bottom of page